Global Citizenship

Our Priorities Innovating for the Future

Because science is best practiced as a globally collaborative enterprise, we encourage cross-functional, multidisciplinary teamwork in all our research and development facilities. Here, scientists with a wide range of expertise in our bioresearch center in Worcester, Massachusetts, participate in a roundtable discussion.

For more than 120 years, Abbott has worked to translate our passion for science, innovation, research and discovery into sustainable solutions to some of the world’s most pressing health care challenges.

Our ongoing investment in research and development – $3.7 billion in 2010 – enables us to foster new solutions for emerging health care challenges. Abbott currently has more than 350 clinical trials under way, with more than 7,000 scientists working in our ten global research and development centers. We expect to deliver more than 20 new or next-generation products and indications over the next year, and more than 75 over the next five years.

Our commitment to innovation extends beyond the laboratory. Across our company, we are working to develop creative new approaches to better anticipate and understand patient and consumer needs – and to translate these insights into new and improved products, services and programs. To maximize the impact of our research and development work, we pursue three key strategies: collaboration, balance and efficiency.